1.71
price down icon6.04%   -0.11
pre-market  시장 영업 전:  1.78   0.07   +4.09%
loading
전일 마감가:
$1.82
열려 있는:
$1.83
하루 거래량:
1.72M
Relative Volume:
0.87
시가총액:
$535.16M
수익:
$6.23M
순이익/손실:
$-95.90M
주가수익비율:
-4.3846
EPS:
-0.39
순현금흐름:
$-68.47M
1주 성능:
+2.40%
1개월 성능:
-1.16%
6개월 성능:
+85.15%
1년 성능:
+21.71%
1일 변동 폭
Value
$1.67
$1.83
1주일 범위
Value
$1.63
$1.96
52주 변동 폭
Value
$0.6513
$2.17

Precigen Inc Stock (PGEN) Company Profile

Name
명칭
Precigen Inc
Name
전화
301-556-9900
Name
주소
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
Name
직원
0
Name
트위터
@precigen
Name
다음 수익 날짜
2025-03-19
Name
최신 SEC 제출 서류
Name
PGEN's Discussions on Twitter

PGEN을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
PGEN
Precigen Inc
1.71 535.16M 6.23M -95.90M -68.47M -0.39
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
509.04 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
634.14 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
605.52 36.93B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
280.96 36.37B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
250.47 27.23B 3.81B -644.79M -669.77M -6.24

Precigen Inc Stock (PGEN) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-03-22 다운그레이드 JP Morgan Neutral → Underweight
2023-05-23 개시 JP Morgan Neutral
2022-11-18 개시 Cantor Fitzgerald Overweight
2021-02-25 개시 Stifel Buy
2021-02-22 개시 Wells Fargo Overweight
2021-02-18 개시 B. Riley Securities Buy
2020-05-08 개시 H.C. Wainwright Buy
모두보기

Precigen Inc 주식(PGEN)의 최신 뉴스

pulisher
Mar 23, 2025

Precigen, Inc. (NASDAQ:PGEN) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 23, 2025
pulisher
Mar 22, 2025

Cantor Fitzgerald raises Precigen stock target to $5 By Investing.com - Investing.com Australia

Mar 22, 2025
pulisher
Mar 22, 2025

10 Hot Biotech Stocks Under $5 - Insider Monkey

Mar 22, 2025
pulisher
Mar 21, 2025

Precigen’s Earnings Call: Positive Outlook Amid Challenges - TipRanks

Mar 21, 2025
pulisher
Mar 21, 2025

Precigen Inc (PGEN) Q4 2024 Earnings Report Preview: What To Exp - GuruFocus.com

Mar 21, 2025
pulisher
Mar 21, 2025

Precigen’s SWOT analysis: biotech firm’s stock poised for potential launch By Investing.com - Investing.com South Africa

Mar 21, 2025
pulisher
Mar 21, 2025

Analysts Are Bullish on Precigen Stock (PGEN) Amid Positive Pipeline Developments - Markets Insider

Mar 21, 2025
pulisher
Mar 21, 2025

ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Precigen, Inc. f/k/a Intrexon Corporation Investors of Important Deadline in Securities Class Action First Filed by the Firm – PGEN, XON - Business Wire

Mar 21, 2025
pulisher
Mar 21, 2025

Stifel maintains Precigen stock Buy rating with $7 target By Investing.com - Investing.com South Africa

Mar 21, 2025
pulisher
Mar 20, 2025

Precigen’s SWOT analysis: biotech firm’s stock poised for potential launch - Investing.com India

Mar 20, 2025
pulisher
Mar 20, 2025

Expert Outlook: Precigen Through The Eyes Of 4 Analysts - Benzinga

Mar 20, 2025
pulisher
Mar 20, 2025

Cantor Fitzgerald raises Precigen stock target to $5 - Investing.com

Mar 20, 2025
pulisher
Mar 20, 2025

Stifel maintains Precigen stock Buy rating with $7 target - Investing.com

Mar 20, 2025
pulisher
Mar 20, 2025

H.C. Wainwright reiterates buy on Precigen stock, maintains $6 target By Investing.com - Investing.com South Africa

Mar 20, 2025
pulisher
Mar 20, 2025

H.C. Wainwright reiterates buy on Precigen stock, maintains $6 target - Investing.com

Mar 20, 2025
pulisher
Mar 20, 2025

Earnings call transcript: Precigen Q4 2024 sees net loss, stock rises By Investing.com - Investing.com South Africa

Mar 20, 2025
pulisher
Mar 20, 2025

Precigen Inc (PGEN) Q4 2024 Earnings Call Highlights: Navigating Challenges and Seizing ... - Yahoo Finance

Mar 20, 2025
pulisher
Mar 20, 2025

Precigen Inc (PGEN) Q4 2024 Earnings Call Highlights: Navigating Challenges and Seizing Opportunities - GuruFocus.com

Mar 20, 2025
pulisher
Mar 20, 2025

Precigen earnings beat by $0.02, revenue fell short of estimates - Investing.com Canada

Mar 20, 2025
pulisher
Mar 19, 2025

Precigen Reports Progress and Financial Results for 2024 - TipRanks

Mar 19, 2025
pulisher
Mar 19, 2025

Precigen Reports Full Year 2024 Financial Results and Business Updates - The Malaysian Reserve

Mar 19, 2025
pulisher
Mar 19, 2025

Precigen, Inc. (PGEN) Reports Q4 Loss, Lags Revenue Estimates - MSN

Mar 19, 2025
pulisher
Mar 19, 2025

Earnings call transcript: Precigen Q4 2024 sees net loss, stock rises - Investing.com Canada

Mar 19, 2025
pulisher
Mar 19, 2025

Precigen Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 19, 2025
pulisher
Mar 19, 2025

Precigen Inc Reports Q4 Net Loss of $(0.47) Per Share, Revenue o - GuruFocus.com

Mar 19, 2025
pulisher
Mar 19, 2025

PRECIGEN, INC. SEC 10-K Report - TradingView

Mar 19, 2025
pulisher
Mar 18, 2025

How Do Things Look For Precigen Inc (NASDAQ: PGEN) In The Short-Term? - Stocks Register

Mar 18, 2025
pulisher
Mar 17, 2025

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Precigen, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm - Business Wire

Mar 17, 2025
pulisher
Mar 14, 2025

Precigen, Inc. (NASDAQ:PGEN) Receives $7.00 Consensus Price Target from Brokerages - Defense World

Mar 14, 2025
pulisher
Mar 14, 2025

Analysts Set Precigen, Inc. (NASDAQ:PGEN) Price Target at $7.00 - MarketBeat

Mar 14, 2025
pulisher
Mar 13, 2025

Precigen to Announce Full Year 2024 Financial Results and Provide Business Updates on March 19th - Quantisnow

Mar 13, 2025
pulisher
Mar 13, 2025

Precigen Gene Therapy Pioneer Reveals 2024 Performance: Key Financial Results Coming March 19 - StockTitan

Mar 13, 2025
pulisher
Mar 11, 2025

Exploring High Growth Tech Stocks In The US Market - Simply Wall St

Mar 11, 2025
pulisher
Mar 11, 2025

Precigen, Inc. (NASDAQ:PGEN) Stock Holdings Increased by Rhumbline Advisers - Defense World

Mar 11, 2025
pulisher
Mar 11, 2025

Precigen (PGEN) Projected to Post Earnings on Tuesday - Defense World

Mar 11, 2025
pulisher
Mar 05, 2025

Is Precigen Inc’s (NASDAQ:PGEN) Stock On The Decline? - Stocks Register

Mar 05, 2025
pulisher
Mar 01, 2025

Why These 15 Biotech Stocks Are Skyrocketing So Far In 2025 - Insider Monkey

Mar 01, 2025
pulisher
Mar 01, 2025

Why Precigen, Inc. (PGEN) is Skyrocketing So Far in 2025 - Insider Monkey

Mar 01, 2025
pulisher
Mar 01, 2025

Precigen (NASDAQ:PGEN) Shares Gap UpWhat's Next? - MarketBeat

Mar 01, 2025
pulisher
Feb 28, 2025

Precigen (NASDAQ:PGEN) Shares Up 7.7%Time to Buy? - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Precigen: UltraCAR-T Development Brings Another Side Of Pipeline Advancement (PGEN) - Seeking Alpha

Feb 28, 2025
pulisher
Feb 26, 2025

FDA advances Precigen’s gene therapy for respiratory disease By Investing.com - Investing.com Australia

Feb 26, 2025
pulisher
Feb 26, 2025

FDA Accepts for Review Precigen RRP Gene Therapy Candidate - Genetic Engineering & Biotechnology News

Feb 26, 2025
pulisher
Feb 25, 2025

Stifel maintains Precigen stock Buy rating, $7 target post-FDA update - Investing.com Australia

Feb 25, 2025
pulisher
Feb 25, 2025

FDA Accepts BLA for Precigen’s Recurrent Respiratory Papillomatosis Gene Therapy PRGN-2012 With Priority Review - CGTLive™

Feb 25, 2025
pulisher
Feb 25, 2025

Decades in, this Germantown biopharma is on the cusp of bringing its first product to market - The Business Journals

Feb 25, 2025
pulisher
Feb 25, 2025

Precigen gets FDA Priority Review for its respiratory tract tumor treatment - MSN

Feb 25, 2025
pulisher
Feb 25, 2025

Stifel maintains Precigen stock Buy rating, $7 target post-FDA update By Investing.com - Investing.com South Africa

Feb 25, 2025
pulisher
Feb 25, 2025

Precigen Says FDA Accepts for Priority Review Application for Recurrent Respiratory Papillomatosis Treatment - Marketscreener.com

Feb 25, 2025

Precigen Inc (PGEN) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$316.73
price down icon 0.98%
$78.54
price down icon 1.06%
$33.76
price up icon 0.03%
$20.24
price down icon 2.17%
$97.05
price down icon 3.57%
biotechnology ONC
$250.47
price down icon 1.08%
자본화:     |  볼륨(24시간):